{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:11:25Z","timestamp":1785539485066,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00384-020-03576-0","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T13:04:12Z","timestamp":1587387852000},"page":"1231-1242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Vitamin D regulates claudin-2 and claudin-4 expression in active ulcerative colitis by p-Stat-6 and Smad-7 signaling"],"prefix":"10.1007","volume":"35","author":[{"given":"Vladana","family":"Domazetovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Iantomasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Giovanni","family":"Bonanomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-0359","authenticated-orcid":false,"given":"Maria","family":"Stio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"3576_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474:307\u2013317","journal-title":"Nature"},{"key":"3576_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrgastro.2014.201","volume":"2","author":"R Atreya","year":"2015","unstructured":"Atreya R, Neurath MF (2015) IBD pathogenesis in 2014: molecular pathways controlling barrier function in IBD. Nat Rev Gastroenterol Hepatol 2:67\u201368","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3576_CR3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","volume":"14","author":"LW Peterson","year":"2014","unstructured":"Peterson LW, Artis D (2014) Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 14:141\u2013153","journal-title":"Nat Rev Immunol"},{"key":"3576_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/bs.ai.2014.11.003","volume":"126","author":"LV Hooper","year":"2015","unstructured":"Hooper LV (2015) Epithelial cell contributions to intestinal immunity. Adv Immunol 126:129\u2013172","journal-title":"Adv Immunol"},{"key":"3576_CR5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gutjnl-2011-300904","volume":"61","author":"S Danese","year":"2012","unstructured":"Danese S (2012) New therapies for inflammatory bowel disease: from the bench to the bedside. Gut 61:918\u2013932","journal-title":"Gut"},{"key":"3576_CR6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.addr.2005.01.009","volume":"57","author":"GJ Feldman","year":"2005","unstructured":"Feldman GJ, Mullin JM, Ryan MP (2005) Occludin: structure, function and regulation. Adv Drug Deliv Rev 57:883\u2013917","journal-title":"Adv Drug Deliv Rev"},{"key":"3576_CR7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.addr.2005.01.005","volume":"57","author":"KJ Mandell","year":"2005","unstructured":"Mandell KJ, Parkos CA (2005) The JAM family of proteins. Adv Drug Deliv Rev 57:857\u2013867","journal-title":"Adv Drug Deliv Rev"},{"key":"3576_CR8","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1083\/jcb.141.7.1539","volume":"114","author":"M Furuse","year":"1998","unstructured":"Furuse M, Fujita K, Hiiragi T et al (1998) Claudin-1 and -2, novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 114:1539\u20131550","journal-title":"J Cell Biol"},{"key":"3576_CR9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/35067088","volume":"2","author":"S Tsukita","year":"2001","unstructured":"Tsukita S, Furuse M, Itoh M (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2:285\u2013293","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3576_CR10","first-page":"S146","volume":"23","author":"T Oshima","year":"2008","unstructured":"Oshima T, Miwa H, Jon T (2008) Changes in the expression of claudins in active ulcerative colitis. Gastroenterology 23:S146\u2013S150","journal-title":"Gastroenterology"},{"key":"3576_CR11","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1242\/jcs.00165","volume":"115","author":"S Amasheh","year":"2002","unstructured":"Amasheh S, Meiri N, Gitter AH, Sch\u00f6neberg T, Mankertz J, Schulzke JD, Fromm M (2002) Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 115:4969\u20134976","journal-title":"J Cell Sci"},{"key":"3576_CR12","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.54","volume":"7","author":"J K\u00f6nig","year":"2016","unstructured":"K\u00f6nig J, Wells J, Cani PD et al (2016) Human intestinal barrier function in health and disease. Clin Transl Gastroenterol 7:e196","journal-title":"Clin Transl Gastroenterol"},{"key":"3576_CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0016-5085(99)70126-5","volume":"116","author":"H Schmitz","year":"1999","unstructured":"Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, Riecken EO, Schulzke JD (1999) Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116:301\u2013309","journal-title":"Gastroenterology"},{"key":"3576_CR14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI113938","volume":"83","author":"JL Madara","year":"1989","unstructured":"Madara JL, Stafford J (1989) Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 83:724\u2013727","journal-title":"J Clin Invest"},{"key":"3576_CR15","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/labinvest.3700316","volume":"85","author":"S Prasad","year":"2005","unstructured":"Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald T, Collins JE (2005) Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Investig 85:1139\u20131162","journal-title":"Lab Investig"},{"key":"3576_CR16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1749-6632.2009.04062.x","volume":"1165","author":"JD Schulzke","year":"2009","unstructured":"Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, Richter J, Bojarski C, Schumann M, Fromm M (2009) Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci 1165:294\u2013300","journal-title":"Ann N Y Acad Sci"},{"key":"3576_CR17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/00365521.2016.1185463","volume":"51","author":"M Stio","year":"2016","unstructured":"Stio M, Retico L, Annese V et al (2016) Vitamin D regulates the tight-junction protein expression in active ulcerative colitis. Scand J Gastroenterol 51:193\u2013199","journal-title":"Scand J Gastroenterol"},{"key":"3576_CR18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2265.2011.04261.x","volume":"76","author":"M Hewison","year":"2012","unstructured":"Hewison M (2012) An update on vitamin D and human immunity. Clin Endocrinol 76:315\u2013325","journal-title":"Clin Endocrinol"},{"key":"3576_CR19","first-page":"151","volume":"5","author":"RF Chun","year":"2014","unstructured":"Chun RF, Liu PT, Modlin RL et al (2014) Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol 5:151\u2013166","journal-title":"Front Physiol"},{"key":"3576_CR20","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.3748\/wjg.v20.i17.4934","volume":"20","author":"KM Reich","year":"2014","unstructured":"Reich KM, Fedorak RN, Madsen K, Kroeker KI (2014) Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review. World J Gastroenterol 20:4934\u20134947","journal-title":"World J Gastroenterol"},{"key":"3576_CR21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ecco-jcc\/jjy025","volume":"12","author":"OH Nielsen","year":"2018","unstructured":"Nielsen OH, Lars Rejnmark L, Moss AC (2018) Role of vitamin D in the natural history of inflammatory bowel disease. J Crohn's Colitis 12:742\u2013752","journal-title":"J Crohn's Colitis"},{"key":"3576_CR22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/apt.12553","volume":"39","author":"VP Mouli","year":"2014","unstructured":"Mouli VP, Ananthakrishnan AN (2014) Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther 39:125\u2013136","journal-title":"Aliment Pharmacol Ther"},{"key":"3576_CR23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1389200217666151210130103","volume":"17","author":"F Laudisi","year":"2016","unstructured":"Laudisi F, Dinallo V, Di Fusco D et al (2016) Smad7 and its potential as therapeutic target in inflammatory bowel diseases. Curr Drug Metab 17:303\u2013306","journal-title":"Curr Drug Metab"},{"key":"3576_CR24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/00365528909091339","volume":"24","author":"JE Lennard-Jones","year":"1989","unstructured":"Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol 24:2\u20136","journal-title":"Scand J Gastroenterol"},{"key":"3576_CR25","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/jclinpath-2013-201885","volume":"66","author":"RM Feakins","year":"2013","unstructured":"Feakins RM (2013) British society of gastroenterology. Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol 66:1005\u20131026","journal-title":"J Clin Pathol"},{"key":"3576_CR26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein- dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"3576_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.mog.0000203864.48255.4f","volume":"22","author":"MG Laukoetter","year":"2006","unstructured":"Laukoetter MG, Bruewer M, Nusrat A (2006) Regulation of the intestinal epithelial barrier by the apical junction complex. Curr Opin Gastroenterol 22:85\u201389","journal-title":"Curr Opin Gastroenterol"},{"key":"3576_CR28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1172\/JCI12821","volume":"108","author":"G Monteleone","year":"2001","unstructured":"Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald T (2001) Blocking Smad7 restores TGF-beta1 signaliNG in chronic inflammatory bowel disease. J Clin Investig 108:601\u2013609","journal-title":"J Clin Investig"},{"key":"3576_CR29","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/ibd.21628","volume":"17","author":"MJ Rosen","year":"2011","unstructured":"Rosen MJ, Frey R, Washington MK et al (2011) STAT-6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction. Inflamm Bowel Dis 17:2224\u20132234","journal-title":"Inflamm Bowel Dis"},{"key":"3576_CR30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1067\/mai.2003.1333","volume":"111","author":"GK Hershey","year":"2003","unstructured":"Hershey GK (2003) IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111:677\u2013690","journal-title":"J Allergy Clin Immunol"},{"key":"3576_CR31","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4049\/jimmunol.1201373","volume":"190","author":"MJ Rosen","year":"2013","unstructured":"Rosen MJ, Chaturvedi R, Washington MK et al (2013) STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines. J Immunol 190:1849\u20131858","journal-title":"J Immunol"},{"key":"3576_CR32","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.4049\/jimmunol.169.8.4417","volume":"169","author":"KB Madden","year":"2002","unstructured":"Madden KB, Whitman L, Sullivan C et al (2002) Role of STAT6 and mast cells in IL-4- and IL-13-induced alterations in murine intestinal epithelial cell function. J Immunol 169:4417\u20134422","journal-title":"J Immunol"},{"key":"3576_CR33","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.1074\/jbc.M110.214965","volume":"286","author":"D Wu","year":"2011","unstructured":"Wu D, Ahrens R, Osterfeld H, Noah TK, Groschwitz K, Foster PS, Steinbrecher KA, Rothenberg ME, Shroyer NF, Matthaei KI, Finkelman FD, Hogan SP (2011) Interleukin-13 (IL-13)\/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent cl- secretion. J Biol Chem 286:13357\u201313369","journal-title":"J Biol Chem"},{"key":"3576_CR34","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI19836","volume":"113","author":"IJ Fuss","year":"2004","unstructured":"Fuss IJ, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S, Yang Z, Exley M, Kitani A, Blumberg RS, Mannon P, Strober W (2004) Nonclassical CD1d-restricted NKT cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 113:1490\u20131497","journal-title":"J Clin Invest"},{"key":"3576_CR35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00054725-200409000-00014","volume":"10","author":"K Kadivar","year":"2004","unstructured":"Kadivar K, Ruchelli ED, Markowitz JE, Defelice ML, Strogatz ML, Kanzaria MM, Reddy KP, Baldassano RN, von Allmen D, Brown KA (2004) Intestinal interleukin-13in pediatric inflammatory bowel disease patients. Inflamm Bowel Dis 10:593\u2013598","journal-title":"Inflamm Bowel Dis"},{"key":"3576_CR36","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1006\/cyto.2000.0744","volume":"12","author":"B Vainer","year":"2000","unstructured":"Vainer B, Nielsen OH, Hendel J, Horn T, Kirman I (2000) Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Cytokine 12:1531\u20131536","journal-title":"Cytokine"},{"key":"3576_CR37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","volume":"129","author":"F Heller","year":"2005","unstructured":"Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, B\u00fcrgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129:550\u2013564","journal-title":"Gastroenterology"},{"key":"3576_CR38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.intimp.2004.11.002","volume":"5","author":"M Stio","year":"2005","unstructured":"Stio M, Treves C, Martinesi M et al (2005) Biochemical effects of KH 1060 and anti-TNF monoclonal antibody on human peripheral blood mononuclear cells. Int Immunopharmacol 5:649\u2013569","journal-title":"Int Immunopharmacol"},{"key":"3576_CR39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","volume":"214","author":"JR Bradley","year":"2008","unstructured":"Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214:149\u2013160","journal-title":"J Pathol"},{"key":"3576_CR40","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/mi.2008.55","volume":"Suppl 1","author":"G Monteleone","year":"2008","unstructured":"Monteleone G, Boirivant M, Pallone F et al (2008) TGF-beta1 and Smad7 in the regulation of IBD. Mucosal Immunol Suppl 1:S50\u2013S53","journal-title":"Mucosal Immunol"},{"key":"3576_CR41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsbmb.2006.07.008","volume":"103","author":"M Stio","year":"2007","unstructured":"Stio M, Martinesi M, Bruni S, Treves C, Mathieu C, Verstuyf A, d'Albasio G, Bagnoli S, Bonanomi AG (2007) The vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease. J Steroid Biochem Mol Biol 103:51\u201360","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3576_CR42","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1172\/JCI65842","volume":"123","author":"W Liu","year":"2013","unstructured":"Liu W, Chen Y, Golan MA et al (2013) Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. Clin Invest 123:3983\u20133996","journal-title":"Clin Invest"},{"key":"3576_CR43","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","volume":"126","author":"EV Loftus Jr","year":"2004","unstructured":"Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influence. Gastroenterology 126:1504\u20131517","journal-title":"Gastroenterology"},{"key":"3576_CR44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/eji.200425491","volume":"35","author":"Y Zhu","year":"2005","unstructured":"Zhu Y, Mahon BD, Froicu M, Cantorna MT (2005) Calcium and 1 alpha,25 Dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 35:217\u2013224","journal-title":"Eur J Immunol"},{"key":"3576_CR45","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.3748\/wjg.v18.i40.5664","volume":"18","author":"G Monteleone","year":"2012","unstructured":"Monteleone G, Caruso R, Pallone F (2012) Role of Smad7 in inflammatory bowel diseases. World J Gastroenterol 18:5664\u20135668","journal-title":"World J Gastroenterol"},{"key":"3576_CR46","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1053\/j.gastro.2005.09.005","volume":"129","author":"G Monteleone","year":"2005","unstructured":"Monteleone G, Del Vecchio Blanco G, Monteleone I et al (2005) Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology 129:1420\u20131429","journal-title":"Gastroenterology"},{"key":"3576_CR47","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/gut.26.11.1197","volume":"26","author":"AD Harries","year":"1985","unstructured":"Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J (1985) Vitamin D status in Crohn\u2019s disease: association with nutrition and disease activity. Gut 26:1197\u20131203","journal-title":"Gut"},{"key":"3576_CR48","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1080\/10408398.2018.1506734","volume":"59","author":"M Ponce de Le\u00f3n-Rodr\u00edguez","year":"2019","unstructured":"Ponce de Le\u00f3n-Rodr\u00edguez M, Guyot JP, Laurent-Babot C (2019) Intestinal in vitro cell culture models and their potential to study the effect of food components on intestinal inflammation. Crit Rev Food Sci Nutr 59:2166\u20132168","journal-title":"Crit Rev Food Sci Nutr"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03576-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-020-03576-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03576-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T23:50:13Z","timestamp":1618876213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-020-03576-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["3576"],"URL":"https:\/\/doi.org\/10.1007\/s00384-020-03576-0","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]},"assertion":[{"value":"4 April 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest related to the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Medical Ethics Committee, and with the Helsinki Declaration of 1975, as revised in 1983. CE May 2, 2011, protocol 0016888, rif. 95\/10.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients prior to their inclusion in this study","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of informed consent\/Human and animal rights and informed consent"}}]}}